Dar Al Dawa Organizes Awareness Lecture on Breast Cancer Early Detection in Collaboration With King Hussein Cancer Center
As part of the “Think Pink” initiative and in collaboration with King Hussein Cancer Center (KHCC), Dar Al Dawa Development & Investment Co. organized a breast cancer early detection campaign, marking the breast cancer awareness Month, through conducting a two-day lecture on October 11-12 at Dar Al Dawa premises in Na’our. The prevention awareness lecture aimed at encouraging women employees at the company overcome their fears and undergo the screening.
Dr. Yassar Qutiba, Head of Early Detection Unit at KHCC emphasized the importance of breast cancer early detection, which contributes in improving the results of cancer treatment when discovered at early stages. Dr. Yassar also explained how to perform the breast self-examination at home and treatment options, highlighting the role of regular self-examination in cancer early detection and treatment. At the end of the lecture awareness brochures were disseminated among attendees that included guidelines on self-examination.
“Our employees are our back bone and their health is a priority, Dar Al Dawa held this campaign as part of our beliefs and responsibility toward our women employees to raise awareness on breast cancer early diagnosis. We believe that by spreading awareness on early detection we can contribute in saving women’s lives.” Said Mr. Khaled Al-Kurdi, Dar Al Dawa Managing Director.
Dar Al Dawa also hosted women who survived from breast cancer and decided to opt for a fighter’s spirit instead of a defeated one. Those women were a big motivation and inspiration to all Dar Al Dawa community through sharing their journey with breast cancer and their survival stories.
Dar Al Dawa
Dar Al Dawa is a MENA-wide leader in pharmaceutical and consumer health products. With a history of more than 40 years, we are a trusted leader and competence center with a reputation for exceptional quality. As a fully integrated pharmaceutical company, we have a long established customer-centered approach to developing, producing, marketing and commercializing high-quality affordable medicines and wellness consumer products in emerging markets, with more than 900 people serving patients in more than 40 countries throughout Middle East, North Africa and Europe.